A 5-HT2A, 5-HT2B, and 5-HT2C receptor agonist; induces calcium accumulation in CHO-K1 cells expressing 5-HT2A, 5-HT2B, or 5-HT2C receptors (EC50s = 309.03, 177.83, and 338.84 nM, respectively, for the human receptors); binds to the 5-HT3 receptor (Ki = 2.1 nM); decreases food intake in rats at 2.5, 5, or 10 mg/kg; restores spinal circuitry function, improves gait regularity, and increases interlimb coordination and limb weight-bearing in a rat model of spinal cord transection-induced hindlimb paralysis at 0.3 mg/kg per day in combination with 8-hydroxy DPAT, electrode stimulation of dorsal and lumbar spine regions, and locomotor training